ROLE OF ADJUVANT CHEMOTHERAPY FOR STAGE II COLON CANCER: EXPERIENCE OF THE MOHAMMED VI UNIVERSITY HOSPITAL CENTER AT ONCOLOGY CENTER IN MARRAKESH
*M. Saadoune, M. Elkhadir, M. Darfaoui, A. Elomrani, M. Khouchani
Stage II colon cancer (CC) is probably one of the best prognosis gastrointestinal tumors seen in our consultations, but often takes a lot of time for physicians to determine appropriate treatment because of the limited benefit of adjuvant chemotherapy (CT) in these patients, together with the limited evidence in this situation. How to choose the best treatment for each individual patient is thus dependent on molecular (microsatellite instability/microsatellite stability status) and clinico-pathological features relevant enough to classify these tumors into low-, intermediate- and high-risk stage II disease and to choose an appropriate attitude for each of these subgroups. The goal of this study was to report the experience of patients with stage II colon cancer in our center as well as the use of adjuvant systemic chemotherapy following curative surgery.
[Full Text Article]